KHAN NAJAT (CEO and President) sold 1.1% of their position (22.41K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $78.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/10/2026ACC: 0001601830-26-000105
DirectorOfficer· CEO and President
Since Feb 2026
-22.41K
Net shares
Net seller
$78.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
22.41K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−22.41K
Price / share
$3.52
Trade value
$78.82K
% of position
1.1%
9/8/2026
2.10M→2.07M
Total
Net shares
−22.41K
Net value
-$78.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 9/8/2026 | S · Sale | −22.41K | $3.52 | $78.82K | 1.1% | 2.10M | 2.07M |
| Total | −22.41K | -$78.82K | ||||||
Derivative Transactions0
No derivative transactions reported